Project Number 5R21NS109847-02 Agency/Funding Organization NINDS Funding Year 2019 View Full Project Details for Inhibiting Translation of Endogenous G4C2-Containing RNA As a Novel Therapy for C9ORF72-ALS Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies c. C9ORF-72 and Progranulin Researcher and Organization Principal Investigator RICHTER, JOEL D Principal Investigator First Name JOEL D Principal Investigator Last Name RICHTER Awardee Organization UNIV OF MASSACHUSETTS MED SCH WORCESTER Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-358: NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) FY Overall Cost $209,375 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
